VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis.
- DOI
- 10.1111/cei.12212
- Published
- 2014 Jan
- Container
- Clinical and experimental immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/cei.12212,
title = {VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis.},
author = {Mendel I and Feige E and Yacov N and Salem Y and Levi I and Propheta-Meiran O and Shoham A and Ishai E and George J and Harats D and Breitbart E},
year = {2014},
journal = {Clinical and experimental immunology},
doi = {10.1111/cei.12212},
url = {https://doi.org/10.1111/cei.12212}
}RIS
TY - JOUR TI - VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis. AU - Mendel I AU - Feige E AU - Yacov N AU - Salem Y AU - Levi I AU - Propheta-Meiran O AU - Shoham A AU - Ishai E AU - George J AU - Harats D AU - Breitbart E PY - 2014 JO - Clinical and experimental immunology DO - 10.1111/cei.12212 UR - https://doi.org/10.1111/cei.12212 ER -
APA
I, M., E, F., N, Y., Y, S., I, L., O, P., A, S., E, I., J, G., D, H., & E, B. (2014). VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis.. Clinical and experimental immunology. https://doi.org/10.1111/cei.12212
Source records
- pubmed · retrieved 2026-09-25T07:12:43.057Z